J. Wallin

Exposure–Response Analysis of Necitumumab Efficacy in Squamous Non‐Small Cell Lung Cancer Patients

E. Chigutsa, A. Long, J. Wallin, 2017, CPT: pharmacometrics & systems pharmacology.

Ifosfamide in malignant mesothelioma: a phase II study.

M. Andersen, A. Krarup-Hansen, G. Mårtensson, 1999, Lung cancer.

Enhancement of the anti‐tumor immune response using a combination of interferon‐γ and B7 expression in an experimental mammary carcinoma

J. Allison, A. Hurwitz, S. E. Townsend, 1998, International journal of cancer.

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

H. Janssen, A. Gaggar, A. Gehring, 2023, The Journal of clinical investigation.

Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19

M. Wurfel, W. Liles, I. Stanaway, 2023, Virulence.

Strong decline of intrahepatic HDV markers and signs of liver inflammation after 48 weeks of treatment with Bulevirtide in chronic hepatitis D patients: Combined intrahepatic results from the clinical trials MYR203 and MYR301

M. Dandri, S. Urban, J. Flaherty, 2023, 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.

Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates

A. Gehring, J. Feld, Y. Ghosheh, 2023, JHEP reports : innovation in hepatology.

Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19

C. Rosenberger, M. Bao, Fang Cai, 2023, Clinical and translational science.